A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.

In modern cardiology, one of the greatest challenges is not treating heart attacks — but identifying silent coronary artery ...

Eli Lilly said its experimental gene-editing therapy cut LDL, or “bad,” cholesterol by up to 62% in an early-stage trial, ...

Women are more likely to face delays in the diagnosis of heart disease and - as a result - are more likely to die, according ...

There’s no cure for obstructive hypertrophic cardiomyopathy (oHCM) — treatments focus on symptom management and preventing complications. But the landscape is changing, and more cutting-edge therapies ...

Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often ...

The Conversation reports C-reactive protein is a superior heart disease risk marker over cholesterol, urging universal ...

Heart disease during pregnancy may be tied to worse heart health in offspring decades later. Here’s what to know.

Experts suggest heart disease risk may start as early as in the womb - Cardiovascular disease is the leading cause of death ...

Women are more likely to face delays in diagnosis of cardiovascular disease and, as a result, they are more likely to die or ...